Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Senescence associated long non-coding RNA 1 (SALRNA1, also called SAL-RNA1 or XLOC_023166) is a long non-coding RNA identified in human cells, notably in type II alveolar epithelial cells. SALRNA1 is downregulated in cellular senescence and functions to modulate the SIRT1-FOXO3a/p53 signaling pathway, thereby reducing cellular senescence induced by stressors such as cigarette smoke. Experimental work suggests that upregulation or overexpression of SALRNA1 can reduce markers of senescence and apoptosis in lung epithelial cells, implicating it as a potential therapeutic target to ameliorate pathological aging processes, especially in lung diseases like COPD. SALRNA1 is considered part of the broader lncRNA family, a class of RNA molecules involved in epigenetic regulation and control of gene expression, with emerging roles in various disease pathologies
Modulation of SIRT1 signaling (SALRNA1 overexpression leads to upregulation of SIRT1, which decreases cellular senescence via regulation of FOXO3a and p53 transcription)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Senescence associated long non-coding RNA 1 (SALRNA1).